These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment. Seo EH; Kim SH; Park SH; Kang SH; Choo IH; J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485 [TBL] [Abstract][Full Text] [Related]
13. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample. Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924 [TBL] [Abstract][Full Text] [Related]
14. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β. Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P; J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660 [TBL] [Abstract][Full Text] [Related]
15. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation. Arenaza-Urquijo EM; Bejanin A; Gonneaud J; Wirth M; La Joie R; Mutlu J; Gaubert M; Landeau B; de la Sayette V; Eustache F; Chételat G Neurobiol Aging; 2017 Nov; 59():72-79. PubMed ID: 28764930 [TBL] [Abstract][Full Text] [Related]
16. Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology. Kleinschmidt M; Schoenfeld R; Göttlich C; Bittner D; Metzner JE; Leplow B; Demuth HU J Alzheimers Dis; 2016; 50(1):111-26. PubMed ID: 26639953 [TBL] [Abstract][Full Text] [Related]
17. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing. Rowe CC; Bourgeat P; Ellis KA; Brown B; Lim YY; Mulligan R; Jones G; Maruff P; Woodward M; Price R; Robins P; Tochon-Danguy H; O'Keefe G; Pike KE; Yates P; Szoeke C; Salvado O; Macaulay SL; O'Meara T; Head R; Cobiac L; Savage G; Martins R; Masters CL; Ames D; Villemagne VL Ann Neurol; 2013 Dec; 74(6):905-13. PubMed ID: 24448836 [TBL] [Abstract][Full Text] [Related]
18. Performance on the Cogstate Brief Battery Is Related to Amyloid Levels and Hippocampal Volume in Very Mild Dementia. Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Bourgeat P; Martins RN; Salvado O; Rowe CC; Masters CL; Maruff P; J Mol Neurosci; 2016 Nov; 60(3):362-370. PubMed ID: 27586003 [TBL] [Abstract][Full Text] [Related]
19. Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved. Hanseeuw B; Dricot L; Lhommel R; Quenon L; Ivanoiu A J Alzheimers Dis; 2016 May; 53(2):651-60. PubMed ID: 27232217 [TBL] [Abstract][Full Text] [Related]
20. Molecular imaging of dementia. Mori T; Maeda J; Shimada H; Higuchi M; Shinotoh H; Ueno S; Suhara T Psychogeriatrics; 2012 Jun; 12(2):106-14. PubMed ID: 22712644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]